Nephropathic Cystinosis in Children: A Ten Year Experience from a Pediatric Nephrology Center in Mashhad, North East of Iran
نویسندگان
1 Medical Student, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2 Department of Pediatric Nephrology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
3 Clinical Research Development Unit of Akbar hospital, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
4 Clinical Research Development Unit of Akbar hospital, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
5 Clinical Research Development Unit of Akbar hospital, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
6 Department of Social Medicine, Azad University of Medical Sciences, Mashhad, Iran.
7 Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
8 Clinical Research Development Unit of Akbar hospital, Faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
doi
10.22038/jpp.2024.84274.5510چکیده
Background: Nephropathic cystinosis is a rare autosomal recessive lysosomal storage disease. Its clinical manifestations include: failure to thrive, fanconi syndrome, ocular findings, growth retardation and end stage renal disease.Methods: This was a retrospective chart review of patients with a diagnosis of nephropathic cystinosis over a ten year period in Dr. Sheikh Children’s Hospital in Mashhad, North East of Iran.Results: 20 patients were included in the study. The most common symptoms leading to the diagnosis were failure to thrive, polyuria, and polydipsia. Kidney involvement was reported in 77% of patients. End stage renal disease was reported in 10% and 2 patients had died because of that. Extrarenal manifestations included: hypothyroidism (25%), anemia (55.5%) and hypophosphatemic rickets (80%).Conclusion: The most important complication of nephropathic cystinosis is end stage kidney disease. Early diagnosis and timely treatment with cysteamin can prevent or delay the complications.
